Literature DB >> 9881259

CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 cases.

J Giron1, C Poey, P Fajadet, N Sans, D Fourcade, J P Senac, J J Railhac.   

Abstract

OBJECTIVE: To treat symptomatic pulmonary aspergilloma in patients who were not considered to be operable.
MATERIAL AND METHODS: Forty patients were treated by CT-guided percutaneous injection of amphotericin paste, the aim being to fill the cavity completely and create an anaerobic environment for the aspergillus. The aspergillomas had developed after bacillary infection and pulmonary fibrosis. Surgery was contra-indicated in these patients because of severe respiratory failure. The authors detail the method of preparation of the paste and the technique of percutaneous injection.
RESULTS: Hemoptysis ceased in all 40 patients, with a follow-up ranging from 6 to 28 months; six patients were also treated with bronchial embolization. In 26 patients, the aspergilloma disappeared and serum tests for aspergillus became negative. Complete disappearance of both the aspergilloma and the cavity was obtained in three patients.
CONCLUSION: This technique appears to be a valuable contribution to non-surgical treatment of inoperable patients with pulmonary aspergilloma, but study should be continued in a larger series to define the exact indications and the interaction with other treatments which have recently been introduced.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881259     DOI: 10.1016/s0720-048x(97)00148-4

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  11 in total

1.  Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.

Authors:  A Capone; S Di Bella; P Chinello; D Chiappetta; C Campoli; N Petrosillo
Journal:  Mycopathologia       Date:  2013-03-23       Impact factor: 2.574

2.  Chronic pulmonary aspergillosis - longterm follow-up over 20 years, a case report.

Authors:  Henry Marshall; Simon Jones; Alan Williams
Journal:  J Radiol Case Rep       Date:  2010-02-01

Review 3.  Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.

Authors:  S Harari
Journal:  Drugs       Date:  1999-10       Impact factor: 9.546

Review 4.  Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.

Authors:  Sanjay H Chotirmall; Maria Teresa Martin-Gomez
Journal:  Mycopathologia       Date:  2017-05-17       Impact factor: 2.574

Review 5.  Aspergillus in the lung: diverse and coincident forms.

Authors:  Susan J Buckingham; David M Hansell
Journal:  Eur Radiol       Date:  2003-05-29       Impact factor: 5.315

6.  Direct transbronchial administration of liposomal amphotericin B into a pulmonary aspergilloma.

Authors:  Takayuki Takeda; Hideki Itano; Ryouhei Kakehashi; Shinichi Fukita; Masahiko Saitoh; Sorou Takeda
Journal:  Respir Med Case Rep       Date:  2014-01-24

7.  Monaldi cavernostomy for lung aspergillosis: A case report.

Authors:  Cornel Petreanu; Alina Croitoru; Alexandru Gibu; Alexandru Zariosu; Nicolae Bacalbasa; Irina Balescu; Camelia Diaconu; Ovidiu Stiru; Mihai Dimitriu; Dragos Cretoiu; Cornel Savu
Journal:  Exp Ther Med       Date:  2021-07-06       Impact factor: 2.447

Review 8.  Aspergillus-associated airway disease, inflammation, and the innate immune response.

Authors:  Sanjay H Chotirmall; Mazen Al-Alawi; Bojana Mirkovic; Gillian Lavelle; P Mark Logan; Catherine M Greene; Noel G McElvaney
Journal:  Biomed Res Int       Date:  2013-07-21       Impact factor: 3.411

9.  Hemoptysis due to fungus ball after tuberculosis: A series of 21 cases treated with hemostatic radiotherapy.

Authors:  Lucas G Sapienza; Maria José L Gomes; Carmelindo Maliska; Antonio N Norberg
Journal:  BMC Infect Dis       Date:  2015-11-26       Impact factor: 3.090

10.  Incidence and etiology of chronic pulmonary infections in patients with idiopathic pulmonary fibrosis.

Authors:  Kyuto Odashima; Naho Kagiyama; Tetsu Kanauchi; Takashi Ishiguro; Noboru Takayanagi
Journal:  PLoS One       Date:  2020-04-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.